HEADER TRANSFERASE 01-DEC-18 6IBX TITLE HUMAN PFKFB3 IN COMPLEX WITH A N-ARYL 6-AMINOQUINOXALINE INHIBITOR 5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PFK/FBPASE 3,6PF-2-K/FRU-2,6-P2ASE BRAIN/PLACENTA-TYPE COMPND 5 ISOZYME,RENAL CARCINOMA ANTIGEN NY-REN-56,IPFK-2; COMPND 6 EC: 2.7.1.105,3.1.3.46; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PFKFB3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CANCER, METABOLISM, KINASE, INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.BANASZAK,H.PAWLIK,A.BIALAS,C.H.FABRITIUS,M.NOWAK REVDAT 4 24-JAN-24 6IBX 1 HETSYN REVDAT 3 29-JUL-20 6IBX 1 COMPND REMARK HETNAM SITE REVDAT 2 13-FEB-19 6IBX 1 JRNL REVDAT 1 23-JAN-19 6IBX 0 JRNL AUTH N.BOUTARD,A.BIALAS,A.SABINIARZ,P.GUZIK,K.BANASZAK,A.BIELA, JRNL AUTH 2 M.BIEN,A.BUDA,B.BUGAJ,E.CIELUCH,A.CIERPICH,L.DUDEK, JRNL AUTH 3 H.M.EGGENWEILER,J.FOGT,M.GAIK,A.GONDELA,K.JAKUBIEC,M.JURZAK, JRNL AUTH 4 A.KITLINSKA,P.KOWALCZYK,M.KUJAWA,K.KWIECINSKA,M.LES, JRNL AUTH 5 R.LINDEMANN,M.MACIUSZEK,M.MIKULSKI,P.NIEDZIEJKO,A.OBARA, JRNL AUTH 6 H.PAWLIK,T.RZYMSKI,M.SIEPRAWSKA-LUPA,M.SOWINSKA, JRNL AUTH 7 J.SZEREMETA-SPISAK,A.STACHOWICZ,M.M.TOMCZYK,K.WIKLIK, JRNL AUTH 8 L.WLOSZCZAK,S.ZIEMIANSKA,A.ZAREBSKI,K.BRZOZKA,M.NOWAK, JRNL AUTH 9 C.H.FABRITIUS JRNL TITL SYNTHESIS OF AMIDE AND SULFONAMIDE SUBSTITUTED N-ARYL JRNL TITL 2 6-AMINOQUINOXALINES AS PFKFB3 INHIBITORS WITH IMPROVED JRNL TITL 3 PHYSICOCHEMICAL PROPERTIES. JRNL REF BIOORG. MED. CHEM. LETT. V. 29 646 2019 JRNL REFN ESSN 1464-3405 JRNL PMID 30626557 JRNL DOI 10.1016/J.BMCL.2018.12.034 REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 44807 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1867 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3496 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 79 REMARK 3 SOLVENT ATOMS : 231 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.62 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.72000 REMARK 3 B22 (A**2) : -0.72000 REMARK 3 B33 (A**2) : 2.34000 REMARK 3 B12 (A**2) : -0.36000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.144 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.137 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.108 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.257 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6IBX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-DEC-18. REMARK 100 THE DEPOSITION ID IS D_1200012968. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-AUG-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46675 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.110 REMARK 200 RESOLUTION RANGE LOW (A) : 47.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 10.44 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.2600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.11 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 9.37 REMARK 200 R MERGE FOR SHELL (I) : 0.99200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.270 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3QPU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2% TACSIMATE, 10% PEG3350, 0.1M REMARK 280 MES/IMIDAZOLE PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 169.62667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 84.81333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 127.22000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 42.40667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 212.03333 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 169.62667 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 84.81333 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 42.40667 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 127.22000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 212.03333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 204 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 15 107.63 -49.27 REMARK 500 GLN A 80 136.06 -27.67 REMARK 500 LYS A 204 -88.46 -122.18 REMARK 500 GLU A 330 -8.76 78.34 REMARK 500 ASP A 350 74.61 -156.04 REMARK 500 GLU A 380 -110.68 -108.59 REMARK 500 CYS A 386 -138.17 -135.40 REMARK 500 ALA A 423 -124.26 55.90 REMARK 500 REMARK 500 REMARK: NULL DBREF 6IBX A 3 446 UNP Q16875 F263_HUMAN 4 447 SEQADV 6IBX A UNP Q16875 ASP 18 DELETION SEQADV 6IBX A UNP Q16875 HIS 19 DELETION SEQADV 6IBX A UNP Q16875 ARG 20 DELETION SEQADV 6IBX A UNP Q16875 PRO 21 DELETION SEQADV 6IBX A UNP Q16875 SER 22 DELETION SEQADV 6IBX A UNP Q16875 LEU 23 DELETION SEQADV 6IBX A UNP Q16875 PRO 24 DELETION SEQADV 6IBX A UNP Q16875 ARG 25 DELETION SEQADV 6IBX A UNP Q16875 SER 26 DELETION SEQADV 6IBX A UNP Q16875 CYS 27 DELETION SEQADV 6IBX A UNP Q16875 GLY 28 DELETION SEQADV 6IBX A UNP Q16875 PRO 29 DELETION SEQADV 6IBX A UNP Q16875 LYS 30 DELETION SEQADV 6IBX A UNP Q16875 LEU 31 DELETION SEQADV 6IBX A UNP Q16875 THR 32 DELETION SEQRES 1 A 429 GLU LEU THR GLN SER ARG VAL GLN LYS ILE TRP VAL PRO SEQRES 2 A 429 VAL ASN SER PRO THR VAL ILE VAL MET VAL GLY LEU PRO SEQRES 3 A 429 ALA ARG GLY LYS THR TYR ILE SER LYS LYS LEU THR ARG SEQRES 4 A 429 TYR LEU ASN TRP ILE GLY VAL PRO THR LYS VAL PHE ASN SEQRES 5 A 429 VAL GLY GLU TYR ARG ARG GLU ALA VAL LYS GLN TYR SER SEQRES 6 A 429 SER TYR ASN PHE PHE ARG PRO ASP ASN GLU GLU ALA MET SEQRES 7 A 429 LYS VAL ARG LYS GLN CYS ALA LEU ALA ALA LEU ARG ASP SEQRES 8 A 429 VAL LYS SER TYR LEU ALA LYS GLU GLY GLY GLN ILE ALA SEQRES 9 A 429 VAL PHE ASP ALA THR ASN THR THR ARG GLU ARG ARG HIS SEQRES 10 A 429 MET ILE LEU HIS PHE ALA LYS GLU ASN ASP PHE LYS ALA SEQRES 11 A 429 PHE PHE ILE GLU SER VAL CYS ASP ASP PRO THR VAL VAL SEQRES 12 A 429 ALA SER ASN ILE MET GLU VAL LYS ILE SER SER PRO ASP SEQRES 13 A 429 TYR LYS ASP CYS ASN SER ALA GLU ALA MET ASP ASP PHE SEQRES 14 A 429 MET LYS ARG ILE SER CYS TYR GLU ALA SER TYR GLN PRO SEQRES 15 A 429 LEU ASP PRO ASP LYS CYS ASP ARG ASP LEU SER LEU ILE SEQRES 16 A 429 LYS VAL ILE ASP VAL GLY ARG ARG PHE LEU VAL ASN ARG SEQRES 17 A 429 VAL GLN ASP HIS ILE GLN SER ARG ILE VAL TYR TYR LEU SEQRES 18 A 429 MET ASN ILE HIS VAL GLN PRO ARG THR ILE TYR LEU CYS SEQRES 19 A 429 ARG HIS GLY GLU ASN GLU HIS ASN LEU GLN GLY ARG ILE SEQRES 20 A 429 GLY GLY ASP SER GLY LEU SER SER ARG GLY LYS LYS PHE SEQRES 21 A 429 ALA SER ALA LEU SER LYS PHE VAL GLU GLU GLN ASN LEU SEQRES 22 A 429 LYS ASP LEU ARG VAL TRP THR SER GLN LEU LYS SER THR SEQRES 23 A 429 ILE GLN THR ALA GLU ALA LEU ARG LEU PRO TYR GLU GLN SEQRES 24 A 429 TRP LYS ALA LEU ASN GLU ILE ASP ALA GLY VAL CYS GLU SEQRES 25 A 429 GLU LEU THR TYR GLU GLU ILE ARG ASP THR TYR PRO GLU SEQRES 26 A 429 GLU TYR ALA LEU ARG GLU GLN ASP LYS TYR TYR TYR ARG SEQRES 27 A 429 TYR PRO THR GLY GLU SER TYR GLN ASP LEU VAL GLN ARG SEQRES 28 A 429 LEU GLU PRO VAL ILE MET GLU LEU GLU ARG GLN GLU ASN SEQRES 29 A 429 VAL LEU VAL ILE CYS HIS GLN ALA VAL LEU ARG CYS LEU SEQRES 30 A 429 LEU ALA TYR PHE LEU ASP LYS SER ALA GLU GLU MET PRO SEQRES 31 A 429 TYR LEU LYS CYS PRO LEU HIS THR VAL LEU LYS LEU THR SEQRES 32 A 429 PRO VAL ALA TYR GLY CYS ARG VAL GLU SER ILE TYR LEU SEQRES 33 A 429 ASN VAL GLU SER VAL CYS THR HIS ARG GLU ARG SER GLU HET H9Z A 501 37 HET POP A 502 9 HET FLC A 503 13 HET F6P A 504 16 HET DMS A 505 4 HETNAM H9Z 3-[[8-(1-METHYLINDOL-6-YL)QUINOXALIN-6-YL]AMINO]-~{N}- HETNAM 2 H9Z [(3~{S})-1-METHYLPIPERIDIN-3-YL]PYRIDINE-4-CARBOXAMIDE HETNAM POP PYROPHOSPHATE 2- HETNAM FLC CITRATE ANION HETNAM F6P 6-O-PHOSPHONO-BETA-D-FRUCTOFURANOSE HETNAM DMS DIMETHYL SULFOXIDE HETSYN F6P FRUCTOSE-6-PHOSPHATE; 6-O-PHOSPHONO-BETA-D-FRUCTOSE; 6- HETSYN 2 F6P O-PHOSPHONO-D-FRUCTOSE; 6-O-PHOSPHONO-FRUCTOSE FORMUL 2 H9Z C29 H29 N7 O FORMUL 3 POP H2 O7 P2 2- FORMUL 4 FLC C6 H5 O7 3- FORMUL 5 F6P C6 H13 O9 P FORMUL 6 DMS C2 H6 O S FORMUL 7 HOH *231(H2 O) HELIX 1 AA1 GLY A 46 ILE A 61 1 16 HELIX 2 AA2 VAL A 70 VAL A 78 1 9 HELIX 3 AA3 SER A 83 ARG A 88 5 6 HELIX 4 AA4 ASN A 91 GLU A 116 1 26 HELIX 5 AA5 THR A 129 ASN A 143 1 15 HELIX 6 AA6 ASP A 156 LYS A 168 1 13 HELIX 7 AA7 SER A 171 LYS A 175 5 5 HELIX 8 AA8 ASN A 178 ALA A 195 1 18 HELIX 9 AA9 ASP A 228 ILE A 241 1 14 HELIX 10 AB1 ASN A 256 GLN A 261 1 6 HELIX 11 AB2 SER A 271 ASN A 289 1 19 HELIX 12 AB3 LEU A 300 ALA A 309 1 10 HELIX 13 AB4 LYS A 318 ASN A 321 5 4 HELIX 14 AB5 ALA A 325 GLU A 329 5 5 HELIX 15 AB6 THR A 332 TYR A 340 1 9 HELIX 16 AB7 TYR A 340 ASP A 350 1 11 HELIX 17 AB8 SER A 361 GLN A 379 1 19 HELIX 18 AB9 HIS A 387 LEU A 399 1 13 HELIX 19 AC1 GLU A 405 LEU A 409 5 5 SHEET 1 AA1 2 LEU A 4 GLN A 6 0 SHEET 2 AA1 2 TRP A 13 PRO A 15 -1 O VAL A 14 N THR A 5 SHEET 1 AA2 6 THR A 65 ASN A 69 0 SHEET 2 AA2 6 ILE A 120 ASP A 124 1 O VAL A 122 N PHE A 68 SHEET 3 AA2 6 THR A 35 VAL A 40 1 N ILE A 37 O PHE A 123 SHEET 4 AA2 6 LYS A 146 VAL A 153 1 O LYS A 146 N VAL A 36 SHEET 5 AA2 6 LEU A 211 ILE A 215 1 O VAL A 214 N GLU A 151 SHEET 6 AA2 6 ARG A 220 ASN A 224 -1 O ARG A 220 N ILE A 215 SHEET 1 AA3 6 GLU A 315 GLN A 316 0 SHEET 2 AA3 6 ARG A 294 THR A 297 1 N VAL A 295 O GLU A 315 SHEET 3 AA3 6 VAL A 382 CYS A 386 1 O ILE A 385 N TRP A 296 SHEET 4 AA3 6 ILE A 248 ARG A 252 1 N TYR A 249 O VAL A 382 SHEET 5 AA3 6 THR A 415 VAL A 422 -1 O LEU A 419 N ILE A 248 SHEET 6 AA3 6 GLY A 425 TYR A 432 -1 O ARG A 427 N THR A 420 CRYST1 102.782 102.782 254.440 90.00 90.00 120.00 P 65 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009729 0.005617 0.000000 0.00000 SCALE2 0.000000 0.011234 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003930 0.00000